Home › Funds › NOESIS CAPITAL MANGEMENT CORP › REGN

NOESIS CAPITAL MANGEMENT CORP position in REGN

REGENERON PHARMACEUTICALS · Health Care

NOESIS CAPITAL MANGEMENT CORP reported holding 33,160 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$25.1M, representing 2.98% of its reported portfolio and ranking #11 among its reported holdings. NOESIS CAPITAL MANGEMENT CORP has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)33.16K sh
Reported value held$25.14M
Portfolio Weight2.98%
First reportedQ1 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NOESIS CAPITAL MANGEMENT CORP's REGN position evolved

NOESIS CAPITAL MANGEMENT CORP first disclosed a stake in REGN in Q1 2025 at 400 shares (US$254K). The position peaked in Q3 2026 at 33,160 shares, worth US$25.1M. Across 7 filings, NOESIS CAPITAL MANGEMENT CORP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 33,160 shares valued at US$25.1M. Notable position changes include a 5191% increase in Q3 2025 (shares rose 36% over the following quarter), a 55% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 400 $253.69K New
Q2 2025 400 $210.00K Hold
Q3 2025 21.16K $11.90M Add
Q4 2025 21.39K $16.51M Add
Q1 2026 21.38K $16.52M Hold
Q2 2026 33.20K $20.70M Add
Q3 2026 33.16K $25.14M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has NOESIS CAPITAL MANGEMENT CORP held REGN?

NOESIS CAPITAL MANGEMENT CORP has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is NOESIS CAPITAL MANGEMENT CORP's current position in REGN?

As of Q3 2026, NOESIS CAPITAL MANGEMENT CORP holds 33.16K shares of REGN (REGENERON PHARMACEUTICALS), valued at $25.14M, representing 2.98% of its reported portfolio and ranking #11.

Has NOESIS CAPITAL MANGEMENT CORP been buying or selling REGN?

In the latest 13F filing (Q3 2026), NOESIS CAPITAL MANGEMENT CORP held unchanged its position in REGN. The position peaked in Q3 2026 at 33.16K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.